|
|
|
Defense witness in Murray case faces contempt fine
Court Feed News |
2011/11/16 11:32
|
A scientist who was the star defense witness in the trial of Michael Jackson's doctor will be in court Wednesday to fight a threatened $1,000 fine for contempt.
Dr. Paul White is a pioneer in the use of the anesthetic propofol. He clashed with Superior Court Judge Michael Pastor over comments in and out of court during Dr. Conrad Murray's trial.
Pastor says White deliberately brought up banned information in his testimony.
Pastor is giving White a chance to appear Wednesday and explain why he should not be found in direct contempt of court and fined $1,000. A member of the trial defense team, Michael Flanagan, is representing him.
Murray is in jail awaiting sentencing for involuntary manslaughter in Jackson's death and is not required to attend the hearing. |
|
|
|
|
|
|
Izard Nobel LLP Announces Class Action Lawsuit
Headline News |
2011/11/15 16:51
|
The law firm of Izard Nobel LLP, which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the District of Maryland on behalf of purchasers of the common stock of Human Genome Sciences, Inc. between July 20, 2009 and November 11, 2010, inclusive. Also included are those who acquired shares in the July 28, 2009 public offering at $14 per share and in the December 2, 2009 public offering at $26.75.
The Complaint charges that HGSI and certain of its officers and directors violated federal securities laws by issuing false and misleading statements concerning Benlysta®, HGSI's potential new drug for the treatment of Systemic Lupus Erythematosus, a chronic, life-threatening autoimmune disease. Specifically, the Complaint alleges that defendants failed to disclose that Benlysta was associated with suicide in clinical drug trials conducted by HGSI.
The Complaint alleges that when the U.S. Food and Drug Administration posted its analysis of Benlysta on the Internet on November 12, 2010, investors learned for the first time of the association between Benlysta and suicide in clinical trials, causing HGSI's common stock price to fall. Meanwhile, the Complaint alleges, during the Class Period, HGSI sold over 44 million shares of its common stock in public offerings at artificially inflated prices, receiving $850 million in net proceeds.
If you are a member of the class, you may, no later than January 10, 2012, request that the Court appoint you as lead plaintiff of the class. A lead plaintiff is a class member that acts on behalf of other class members in directing the litigation. Although your ability to share in any recovery is not affected by the decision whether or not to seek appointment as a lead plaintiff, lead plaintiffs make important decisions which could affect the overall recovery for class members.
While Izard Nobel LLP has not filed a lawsuit against the defendants, to view a copy of the Complaint initiating the class action or for more information about the case, and your rights, visit: www.izardnobel.com/humangenomesciences/, or contact Izard Nobel LLP toll-free: (800)797-5499, or by e-mail: firm@izardnobel.com. For more information about class action cases in general, please visit our website: www.izardnobel.com. |
|
|
|
|
|
|
Supreme Court refuses to hear Brooks appeal
Lawyer Blog News |
2011/11/15 15:51
|
The Supreme Court has denied a last minute appeal from an Ohio man scheduled to be executed Tuesday morning.
The court on Tuesday denied appeals from Reginald Brooks, who is scheduled to be executed for fatally shooting his three sons while they slept.
State and U.S. courts have rejected attorneys' arguments that the 66-year-old Brooks is not mentally competent and that the government withheld relevant evidence that could have affected Brooks' case.
The appeals first went to Justice Elena Kagan and then to the rest of the court, where it was rejected without comment. |
|
|
|
|
|
|
Scott+Scott LLP Announces Securities Class Action Lawsuit
Class Action News |
2011/11/14 18:39
|
Scott+Scott LLP filed a class action complaint against Human Genome Sciences, Inc., certain of the Company's senior officers and directors and GlaxoSmithKline plc in the U.S. District Court for the District of Maryland. The action for violations of the Securities Exchange Act of 1934 is brought on behalf of those purchasing the common stock of HGSI between July 20, 2009 and November 11, 2010, inclusive (the "Class Period"), including all persons who acquired the common stock of HGSI in the Company's July 28, 2009 public offering at $14 per share and in its December 2, 2009 public offering of common stock at $26.75.
If you purchased the common stock of HGSI during the Class Period and wish to serve as a lead plaintiff in the action, you must move the Court no later than 60 days from today. Any member of the investor class may move the Court to serve as lead plaintiff through counsel of its choice, or may choose to do nothing and remain an absent class member. If you wish to discuss this action or have questions concerning this notice or your rights, please contact Scott+Scott (scottlaw@scott-scott.com), (800) 404-7770, (860) 537-5537 or visit the Scott+Scott HGSI Pharmaceutical website for more information: www.scott-scott.com/cases/hgs.html. There is no cost or fee to you.
The complaint filed in the action alleges that, during the Class Period, HGSI issued false and misleading statements concerning Benlysta(R), the Company's potential new drug for the treatment of Systemic Lupus Erythematosus, a chronic, life-threatening autoimmune disease. Specifically, the complaint alleges that defendants failed to disclose that Benlysta was associated with suicide in clinical drug trials conducted by the Company.
The complaint alleges that when the U.S. Food and Drug Administration posted its analysis of Benlysta on the Internet on November 12, 2010, investors learned for the first time of the association between Benlysta and suicide in clinical trials of the drug, causing HGSI's common stock price to decline precipitously. Meanwhile, the complaint alleges, during the Class Period, HGSI sold to investors more than 44 million shares of its common stock in public offerings at artificially inflated prices, receiving $850 million in net proceeds.
Scott+Scott has significant experience in prosecuting major securities, antitrust and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals and other entities worldwide. |
|
|
|
|
|
|
Norway killer claims mantle of resistance leader
Court Feed News |
2011/11/14 18:39
|
The anti-Muslim extremist who confessed to a bombing and shooting massacre that killed 77 people in Norway tried to declare himself a resistance leader Monday at his first public court hearing but was quickly cut off by the judge.
Anders Behring Breivik was escorted by guards into an Oslo court room packed with dozens of reporters and spectators, including survivors of his rampage at a youth camp near the capital who were seeing him in person for the first time since the July 22 attack.
"I am a military commander in the Norwegian resistance movement," Breivik said before the judge interrupted him and told him to stick to the issue at hand — his further detention.
The court extended his custody 12 more weeks until Feb. 6, but decided to gradually lift the restrictions on his media access, visitors and mail. Breivik is being held pending his trial on terror charges.
If found guilty, he could be sentenced to 21 years in prison. An alternative custody arrangement — if he is still considered a danger to the public — could keep him behind bars indefinitely.
At the end of Monday's hearing, the 32-year-old Norwegian asked Judge Torkjel Nesheim if he could address survivors and victims' relatives but was turned down. |
|
|
|
|
|
|
Ind. teen who strangled brother seeks sentence cut
Criminal Law Updates |
2011/11/14 15:40
|
An Indiana teenager who strangled his 10-year-old brother and admired a fictional serial killer should not have been sentenced to life in prison without parole because he was mentally ill, his attorney argued in appealing for a lighter sentence.
Defense lawyer Leanna Weissmann also argued that the judge erred when he let an expert who had never met Andrew Conley testify that the teen might be a psychopath.
"Speculation inferring that a suicidal 17-year-old boy who had never been in trouble in his life is a psychopath from a doctor who never took the time to even talk with the boy has no place in our courtrooms ... and in a decision as to whether that boy will spend the rest of his life in prison," Weissmann wrote in a court brief.
The Indiana Supreme Court will hear arguments on Conley's appeal Monday in South Bend. Conley, now 19, unexpectedly pleaded guilty as his trial was set to begin in September 2010. He was sentenced to life without parole following a five-day hearing before a judge in which his videotaped confession was played.
Conley, then 17, told police he choked his brother, Conner, on Nov. 28, 2009, while they were wrestling at their home in the Ohio River town of Rising Sun. After the boy passed out, Conley dragged him into the kitchen, put on gloves and continued strangling him for at least 20 minutes before wrapping the boy's head in two plastic bags. |
|
|
|
|
|
|
Recent Lawyer News Updates |
|
|
Lawyer News RSS
